Xanthotoxin reverses Parkinson's disease-like symptoms in zebrafish larvae and mice models: a comparative study.
Researchers evaluated the antiparkinsonian effects of furanocoumarin-xanthotoxin using two behavioral animal models. One model involved zebrafish larvae treated with 6-hydroxydopamine, and the other involved mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. The results of the study suggest that furanocoumarin-xanthotoxin may have potential therapeutic effects on Parkinson's disease. However, further research is needed to fully understand the implications of these findings and to develop this treatment further.
- Kozioł E et al (2021).
- Pharmacol Rep.
- PubMed:
- 32700246